title: Editorial Commentary: Scaling Up Antiretroviral Therapy in Africa: Are We There Yet?
authors.affiliation: Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, California.
authors.forename: Justen
authors.initials: J
authors.lastname: Manasa
authors.affiliation: Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, California.
authors.forename: David
authors.initials: D
authors.lastname: Katzenstein
mesh_terms: D000349:Africa; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans
chemical_list: D044966:Anti-Retroviral Agents
keywords: LMICs; antiretroviral therapy; efavirenz; nevirapine; tenofovir